Faeth Therapeutics earnings were -$184.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest FTH earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$170.2M, up 3,509% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FTH reported annual earnings of -$21.1M, with -30.1% growth. The next FTH earnings date is Aug 4, 2026.
What were Faeth Therapeutics's earnings last quarter?
Faeth Therapeutics (NASDAQ: FTH) reported Q1 2026 earnings per share (EPS) of -$131.45, up 2,311.93% year over year. Total FTH earnings for the quarter were -$170.24 million. In the same quarter last year, Faeth Therapeutics's earnings per share (EPS) was -$5.45.
The next FTH earnings call is Invalid Date. Add FTH to your watchlist to be reminded of Faeth Therapeutics's next earnings date.
What was FTH's earnings growth in the past year?
As of Faeth Therapeutics's earnings date in Q2 2026, Faeth Therapeutics's earnings has grown year over year. FTH earnings in the past year totalled -$184.46 million.
Is Faeth Therapeutics profitable or losing money?
As of the last Faeth Therapeutics earnings report, Faeth Therapeutics is currently losing money. Faeth Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$184.46 million, a 535.43% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.